Bevantolol hydrochloride

Chemical name: (±)-1-[3,4-dimethoxyphenethyl]amino-3-(m-tolyloxy)-2-propanol hydrochloride. Chemical structure: Molecular formula: C20H27NO4・HCL Molecular weight: 381.89

Drug name: Other drugs that inhibit the sympathetic nervous system (such as reserpine) Clinical symptoms/treatment methods: Excessive sympathetic inhibition can lead to symptoms such as bradycardia or hypotension, so the dosage should be reduced and the drug should be administered with caution. Mechanism/risk factors: There is a possibility of enhancing the mutual sympathetic inhibition. Drug name: Hypoglycemic drugs (including insulin, tolbutamide, etc.) Clinical symptoms/treatment methods: It can enhance the hypoglycemic effect and mask the signs of hypoglycemia such as tachycardia, so attention should be paid to the blood sugar level and the drug should be administered with caution. Mechanism/risk factors: Due to the β-blocking effect, the recovery from the hypoglycemic state can be delayed, and at the same time, the symptoms of the sympathetic nervous system associated with hypoglycemia can be masked. Drug name: Calcium antagonists (including verapamil hydrochloride) Clinical symptoms/treatment methods: Combined use with β-blockers can lead to enhanced interaction effects, excessive blood pressure reduction or cardiac function inhibition, so the drug should be administered with caution. Mechanism/risk factors: It can enhance the hypotensive effect of the negative interaction between the two. Drug name: Clonidine Clinical symptoms/treatment methods: There is a possibility of aggravating the rebound phenomenon after clonidine is discontinued, so when clonidine is discontinued, it should be noted that this product should be temporarily discontinued first. Mechanism/risk factors: Discontinuation of clonidine can increase norepinephrine in the blood. Combined use with beta-blockers can block the action of beta receptors (vasodilation) and strengthen the action of alpha receptors (vasoconstriction), causing a sharp increase in blood pressure. Drug name: Antiarrhythmic drugs (including disopyramide, procainamide, ajmaline, etc.) Clinical symptoms/treatment methods: It can excessively inhibit cardiac function, so the dosage should be reduced, etc., and the drug should be administered with caution. Mechanism/risk factors: There is a possibility of enhancing the inhibitory effect of each other on cardiac function.

Chemical name: 1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol hydrochloride Molecular weight: C20H27NO4·HCl

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.